secwatch.observer — SEC 8-K summary
======================================

Issuer:     Akari Therapeutics Plc (AKTX)
CIK:        0001541157
Form:       8-K
Filed at:   2025-09-29T23:59:59+00:00
Accession:  0001493152-25-016039
Event type: debt
Sentiment:  neutral
Materiality: 0.50
Item codes: 8.01
LLM model:  deepseek-v4-flash:cloud@v2

Akari closes final tranche of August 2025 notes offering for $250K purchase price
--------------------------------------------------------------------------------

- Aggregate purchase price of $3 million for notes with 20% original issuance discount.
- Total principal amount issued approximately $3.8 million across all tranches.
- Final tranche: $312,500 principal issued for $250,000 purchase price.
- Notes are unsecured promissory notes issued under note purchase agreements dated August 1, 2025.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1541157/000149315225016039/0001493152-25-016039-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1541157/000149315225016039/form8-k.htm
  HTML page:      https://secwatch.observer/filing/0001493152-25-016039

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer